Completed
Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese Patients
NCT00481975
- Conditions
- Body Weight, Bulimia, Eating Disorders, +11 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
- Sanofi-Aventis Administrative Office Helsinki, Finland
- Sanofi-Aventis Administrative Office Paris, France
- Sanofi-Aventis Administrative Office Gouda, Netherlands